BioWorld-International-2004-08-18
Evolva Raises EUR12M To Drive Molecular Evolution Platform
Evolva Raises EUR12M To Drive Molecular Evolution Platform
Evolva SA raised 12 million in a Series A round to further develop its Watchmaker platform, which employs yeast artificial chromosomes and flow cytometry for the synthesis and selection of novel compounds. (BioWorld International)

